Journal of Invasive Cardiology最新文献_第4页

Late degeneration of a transcatheter aortic valve replacement presenting with flail leaflet. 经导管主动脉瓣置换术晚期退变表现为连枷叶。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/26.00064

Leila Alizadeh, Maria Eleni Drosou, Takayuki Onishi, Roya Anahita Mousavi, Amit Hooda, Sahil Khera, Lucy M Safi, George D Dangas, Gilbert H L Tang, Samin K Sharma, Annapoorna S Kini, Stamatios Lerakis

引用次数: 0

Beyond the valve: right heart dysfunction, cardiorenal interactions, and prognosis in low-flow, low-gradient aortic stenosis. 瓣膜外：低流量、低梯度主动脉瓣狭窄患者的右心功能障碍、心肾相互作用和预后。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/26.00140

Neda Dianati-Maleki, Puja B Parikh

引用次数: 0

Real-world analysis of outcomes of patients undergoing coronary intravascular lithotripsy versus atherectomy for calcified coronary artery disease: findings from the TriNetX database. 接受冠状动脉血管内碎石术与动脉粥样硬化切除术治疗钙化冠状动脉疾病患者的现实世界结果分析：来自TriNetX数据库的发现

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/25.00351

Vikash Jaiswal, Muhammad Hanif, Yusra Mashkoor, Aymen Ahmed, Gregory Mishkel, Jonathan Rosenberg, Mark J Ricciardi, Arman Qamar

{"title":"Real-world analysis of outcomes of patients undergoing coronary intravascular lithotripsy versus atherectomy for calcified coronary artery disease: findings from the TriNetX database.","authors":"Vikash Jaiswal, Muhammad Hanif, Yusra Mashkoor, Aymen Ahmed, Gregory Mishkel, Jonathan Rosenberg, Mark J Ricciardi, Arman Qamar","doi":"10.25270/jic/25.00351","DOIUrl":"10.25270/jic/25.00351","url":null,"abstract":"Objectives: Coronary intravascular lithotripsy (IVL) and coronary atherectomy are increasingly used for calcified coronary lesions, yet comparative data on their cardiovascular benefits remain limited. This real-world study compared outcomes of coronary IVL vs atherectomy using the TriNetX Global Collaborative Network.Methods: Adult patients (≥18 years) undergoing PCI with either IVL or atherectomy between 2021 and 2024 were identified using procedural and diagnosis codes. Propensity score matching (1:1) balanced baseline demographics, comorbidities, laboratory values, and concomitant medications. The primary endpoint was all-cause mortality (ACM), while secondary endpoints included major adverse cardiovascular events (MACE), heart failure exacerbation (HFE), and procedural safety outcomes.Results: Among 51 856 patients, 18 686 underwent IVL and 33 170 underwent atherectomy. After matching, 13 617 patients were retained in each group. At 30 days, IVL was associated with significantly lower risks of ACM (risk ratio [RR]: 0.67; 95% CI, 0.60-0.75; P < .001), MACE (RR: 0.42, 95% CI, 0.36-0.48; P < .001), and HFE (RR: 0.64; 95% CI, 0.57-0.72; P < .001) compared with atherectomy. These benefits persisted at 1 year for ACM (RR: 0.78; 95% CI, 0.73-0.84; P < .001), MACE (RR: 0.66; 95% CI, 0.60-0.72; P < .001), and HFE (RR: 0.79; 95% CI, 0.73-0.85; P < .001). Safety outcomes were comparable between groups.Conclusions: In this propensity-matched, real-world cohort, IVL was associated with lower mortality and fewer adverse cardiovascular events than atherectomy, with a comparable safety profile. Given the likelihood of residual selection bias, these observational findings require confirmation in randomized trials.","PeriodicalId":49261,"journal":{"name":"Journal of Invasive Cardiology","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unmasking the true culprit in ST-segment elevation myocardial infarction with coronary artery aneurysm. 揭示st段抬高型心肌梗死伴冠状动脉瘤的真正元凶。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/26.00086

Elaaha Anwari, Fardin Hamidi, Denitsa Meteva, Ulf Landmesser, Youssef Abdelwahed

引用次数: 0

Left-sided inferior vena cava: an unusual obstacle to leadless pacemaker implantation. 左侧下腔静脉：无铅起搏器植入的不寻常障碍。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/26.00030

John Cheong-Hin Chan, Kwok-Ho Yau, Kin-Lam Tsui

引用次数: 0

Catastrophic right coronary artery dissection after surgical removal of coronary chimney stents following valve-in-valve transcatheter aortic valve implantation. 经导管瓣内主动脉瓣植入术后切除冠状动脉烟囱支架后的灾难性右冠状动脉夹层。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-09-01 DOI: 10.25270/jic/26.00074

Paula Vela Martín, Kristian Rivera, Laura Esteban Lucía, Juan Francisco Oteo Domínguez

引用次数: 0

Transcatheter stenting for severe native aortic coarctation. 重度原生主动脉缩窄的经导管支架置入术。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-08-31 DOI: 10.25270/jic/26.00265

Devesh Kumar, Anwar Hussan Ansari, Archana Malik, Surbhit Bhaduria, Pahul Ahuja, Puneet Gupta, Anunay Gupta, Ranjith Nath

引用次数: 0

Floating atrial septal defect occluder in the left atrium. 左心房浮动房间隔缺损封堵器。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-08-28 DOI: 10.25270/jic/26.00290

Neeraj Shah, Raveen Bazaz, Bassel Sayegh, Mitsugu Ogawa, Dennis Phillips, Benjamin Kristobak

引用次数: 0

Phenotype-specific mitral regurgitation trajectories following transcatheter aortic valve replacement in low-flow aortic stenosis. 经导管主动脉瓣置换术后低流量主动脉瓣狭窄的表型特异性二尖瓣反流轨迹。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-08-26 DOI: 10.25270/jic/26.00155

Akarsh Sharma, Esha Vaish, Eileen Galvani, Annapoorna S Kini, Samin K Sharma, Stamatios Lerakis

{"title":"Phenotype-specific mitral regurgitation trajectories following transcatheter aortic valve replacement in low-flow aortic stenosis.","authors":"Akarsh Sharma, Esha Vaish, Eileen Galvani, Annapoorna S Kini, Samin K Sharma, Stamatios Lerakis","doi":"10.25270/jic/26.00155","DOIUrl":"https://doi.org/10.25270/jic/26.00155","url":null,"abstract":"Objectives: Mitral regurgitation (MR) evolution after transcatheter aortic valve replacement (TAVR) in low-flow aortic stenosis (LFAS) is poorly characterized. The authors evaluated MR trajectories across LFAS phenotypes, predictors of MR worsening, and associations with clinical outcomes.Methods: The authors retrospectively studied 614 patients with LFAS undergoing TAVR: 153 with low-flow high-gradient (LFHG) (24.9%), 155 with classical low-flow low-gradient (cLFLG) (25.2%), and 306 with paradoxical low-flow low-gradient (pLFLG) (49.8%). MR severity was abstracted from clinical echocardiography reports using a 6-level ordinal scale. MR worsening was defined as a grade increase of at least 1 from baseline MR at approximately 30 days or 1 year. Multivariable logistic models identified predictors of MR worsening. Kaplan-Meier and Cox models evaluated associations of MR trajectory and LFAS subtype with all-cause death, heart failure hospitalization, and their composite.Results: Among 614 LFAS patients, 443 had 30-day and 290 had 1-year echocardiographic follow-up. At 30 days, MR trajectory differed significantly across LFAS phenotypes, with the highest rate of worsening in cLFLG and the lowest in LFHG. At 1 year, unadjusted MR trajectory distributions did not differ significantly across phenotypes. In adjusted logistic models, cLFLG remained independently associated with MR worsening at both timepoints. MR worsening was associated with worse unadjusted outcomes at 30 days but was not independently associated with the composite endpoint after multivariable adjustment. LFAS phenotype, particularly cLFLG, remained the dominant predictor of adverse clinical outcomes.Conclusions: MR evolution after TAVR is phenotype-specific; patients with cLFLG have the highest risk of MR worsening and lowest event-free survival, supporting phenotype-informed post-TAVR surveillance.","PeriodicalId":49261,"journal":{"name":"Journal of Invasive Cardiology","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148876374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Giant hepatic artery aneurysm presenting with a hyperattenuating crescent sign: successful single-plug endovascular exclusion. 巨大肝动脉瘤表现为高衰减新月形征象：成功的单栓血管内排除。

IF 1.6 4区医学

Journal of Invasive Cardiology Pub Date : 2026-08-21 DOI: 10.25270/jic/26.00276

Ricardo de Souza Alves Ferreira, Guilherme Evangelista Rezende, Raphael França Lacerda de Andrade, José Luís Attab Dos Santos

引用次数: 0